Excited to share our research article, featured on the cover! 🎉 Special thanks to Alejandro Campos M.D. for his expertise and creativity in drafting the pathway #teamA Andres Acosta Wissam Ghusn Daniela Hurtado A. M.D., Ph.D. 🇪🇨

Just met Wissam Ghusn #DDW2024 presenting amazing work on predictors of Semaglutude intolerance... ✔️lower BMI ✔️higher individualized metabolic severity score ✔️older age Important work to help us safely prescribe AOMs

🥇Stunning ideas shared by Wissam Ghusn & Marcel Yibirin, MD, MPH!! Great BU/BMC IM Residency representation today at #DDW2024

Had a blast catching up with friends and mentors at #DDW2024! So many awesome insights and great conversations! Digestive Disease Week

Such an important topic in #BariatricSurgery & Pts w #Obesity. The inequity involves RCTs too ⬇️ representation of elderly 👵🏼 ⬇️ representation of males 👨🏽‍💼 ⬇️ representation of non-white 🌎 RCTs tend to be state specific Top researcher Wissam Ghusn ⭐️ americanjournalofsurgery.com/article/S0002-…

Weight loss outcomes with #semaglutide based on #diabetes severity using the individualized metabolic surgery (IMS) score Lower IMS severity was associated with greater weight loss in patients with #obesity and Type 2 Diabetes thelancet.com/journals/eclin…

Excited to share our latest study led by the 🌟 Wissam Ghusn ! 🚀 We found that patients with obesity and T2D who had lower IMS severity achieved significantly better weight loss with semaglutide. Mild-moderate IMS: 8.3% vs. severe IMS: 5.5% after 12 months. #obesityresearch

Important & interesting study by Wissam Ghusn & Andres Acosta at Mayo Clinic using metabolic surgery score predictor to assess weight loss in #T2D & #obesity. More evidence that earlier is better to intervene with GLP-1s or surgery. Better weight loss on fewer T2D meds and < time

🍯 DOUBLE DIABETES (Type1 Diabetes & obesity)🍯 #BariatricSurgery in T1D vs T2D pts on insulin 🔺Weight loss post MBS was similar for T1D & insulin-treated T2D ⬇️ in daily insulin 💉doses (140.5 to 77.5 units) 👉🏻 Do NOT hesitate to offer MBS for T1D onlinelibrary.wiley.com/doi/full/10.11…

🫀🫁 Obesity, organ failure & transplantation: Review of the role of bariatric surgery in transplant candidates & recipients 🫘🥩 12 surgeons, 2 societies, 2 publishers to benefit many patients (SAGES is in Long Beach in 2025! & ASTS) link.springer.com/article/10.100… amjtransplant.org/article/S1600-…

Shedding More than Weight: #BariatricSurgery & Journey to Insulin Independence in Insulin-Treated Type 2 #Diabetes 🚩 287 pts w T2D & insulin dependance 🔘 50% diabetes remission 💉 Insulin use ⬇️ from 100% to 36% 💊 Oral med use ↘️ from 79% to 38% jogs.org/article/S1091-…

🔴 New Publication: Immunomodulators, Biologic Therapies, and Small Molecules in IBD and solid organ transplants ▪️ Assess safety of IBD therapies with immunosuppressants ▪️ Liver, Renal, and Heart transplants pubmed.ncbi.nlm.nih.gov/39145836/ Jana G Hashash, MD, MSc Francis (Frank) Farraye, MD, MSc Shabana Pasha, M.D.

My abstract was accepted! Excited to meet fellow Rheumies at #ACR2024 in D.C.! Huge thanks to Wissam Ghusn and Joerg Ermann for their mentorship on this one!

GLP-1RA Review Article: Liraglutide vs Semaglutide vs Tirzepatide 🔸Weight loss outcomes 🔸Side effect profile 🔸New concerns (e.g., aspiration risk and colonoscopy bowel preparation) Daniela Hurtado A. M.D., Ph.D. 🇪🇨 Obesity Medicine Association sciencedirect.com/science/articl…